BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18353447)

  • 1. Anti-obesity drugs and neural circuits of feeding.
    Adan RA; Vanderschuren LJ; la Fleur SE
    Trends Pharmacol Sci; 2008 Apr; 29(4):208-17. PubMed ID: 18353447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine control of food intake.
    Valassi E; Scacchi M; Cavagnini F
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):158-68. PubMed ID: 18061414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New targets for obesity pharmacotherapy.
    Aronne LJ; Thornton-Jones ZD
    Clin Pharmacol Ther; 2007 May; 81(5):748-52. PubMed ID: 17438540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appetite signaling: from gut peptides and enteric nerves to brain.
    Näslund E; Hellström PM
    Physiol Behav; 2007 Sep; 92(1-2):256-62. PubMed ID: 17582445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of gut hormones in controlling the food intake: what is their role in emerging diseases?
    Del Prete A; Iadevaia M; Loguercio C
    Endocrinol Nutr; 2012 Mar; 59(3):197-206. PubMed ID: 22300605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of peptide YY in integrative gut physiology and potential role in obesity.
    Grudell AB; Camilleri M
    Curr Opin Endocrinol Diabetes Obes; 2007 Feb; 14(1):52-7. PubMed ID: 17940420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of energy homeostasis by insulin and leptin: targeting the arcuate nucleus and beyond.
    Könner AC; Klöckener T; Brüning JC
    Physiol Behav; 2009 Jul; 97(5):632-8. PubMed ID: 19351541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin receptor stimulation of the medial nucleus accumbens causes differential effects on food intake and locomotion.
    Pratt WE; Blackstone K; Connolly ME; Skelly MJ
    Behav Neurosci; 2009 Oct; 123(5):1046-57. PubMed ID: 19824770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain neurotransmitters in food and drug reward.
    Hoebel BG
    Am J Clin Nutr; 1985 Nov; 42(5 Suppl):1133-50. PubMed ID: 2865893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural mechanisms underlying obesity and drug addiction.
    Trinko R; Sears RM; Guarnieri DJ; DiLeone RJ
    Physiol Behav; 2007 Aug; 91(5):499-505. PubMed ID: 17292426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
    Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
    Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perinatal undernutrition-induced obesity is independent of the developmental programming of feeding.
    Orozco-Sólis R; Lopes de Souza S; Barbosa Matos RJ; Grit I; Le Bloch J; Nguyen P; Manhães de Castro R; Bolaños-Jiménez F
    Physiol Behav; 2009 Mar; 96(3):481-92. PubMed ID: 19100759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peptide YY: a new strategy for the treatment of obesity].
    Palop OG; Caixàs A
    Endocrinol Nutr; 2009 Jan; 56(1):1-3. PubMed ID: 19627701
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of metergoline and 8-OH-DPAT injections into arcuate nucleus and lateral hypothalamic area on feeding in female rats during the estrous cycle.
    Steffens SM; da Cunha IC; Beckman D; Lopes AP; Faria MS; Marino-Neto J; Paschoalini MA
    Physiol Behav; 2008 Oct; 95(3):484-91. PubMed ID: 18694771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide YY: obesity's cause and cure?
    Tschöp MH; Ravussin E
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1131-3. PubMed ID: 17848627
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular mechanisms of fat preference and overeating.
    Gaillard D; Passilly-Degrace P; Besnard P
    Ann N Y Acad Sci; 2008 Oct; 1141():163-75. PubMed ID: 18991957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms underlying current and future anti-obesity drugs.
    Adan RA
    Trends Neurosci; 2013 Feb; 36(2):133-40. PubMed ID: 23312373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. My brain made me do it, and my gut didn't help.
    Menzies J
    J Neuroendocrinol; 2012 Sep; 24(9):1272-3. PubMed ID: 22897412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretogranin II binds to secretogranin III and forms secretory granules with orexin, neuropeptide Y, and POMC.
    Hotta K; Hosaka M; Tanabe A; Takeuchi T
    J Endocrinol; 2009 Jul; 202(1):111-21. PubMed ID: 19357184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Too fat to fly? New brain circuits regulate obesity in Drosophila.
    Kaun KR; Heberlein U
    Neuron; 2009 Aug; 63(3):279-81. PubMed ID: 19679067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.